Studies
Genomics from LCCC1525: A Priming Dose of Cyclophosphamide Prior to Pembrolizumab to Treat mTNBC
Genomics from LCCC1525: A Priming Dose of Cyclophosphamide Prior to Pembrolizumab to Treat mTNBC
Request Access
Overview
Selected Publications (1)
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer
Carey K. Anders, M. Woodcock, A. Swearingen, et al.. (2022). Journal for Immunotherapy of Cancer. Cited 17 times.
https://doi.org/10.1136/jitc-2021-003427
